Bayesian Capital Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,300
Closed -$1.32M 738
2024
Q3
$1.32M Buy
+20,300
New +$1.3M 0.15% 196
2024
Q2
Sell
-8,438
Closed -$715K 810
2024
Q1
$715K Buy
+8,438
New +$670K 0.07% 367
2022
Q4
Sell
-17,700
Closed -$1.16M 826
2022
Q3
$1.16M Buy
+17,700
New +$1.36M 0.24% 116
2022
Q2
Sell
-11,933
Closed -$1.1M 832
2022
Q1
$1.1M Buy
11,933
+5,200
+77% +$488K 0.16% 190
2021
Q4
$682K Buy
+6,733
New +$686K 0.22% 139
2020
Q1
Sell
-1,982
Closed -$217K 804
2019
Q4
$217K Sell
1,982
-406
-17% -$41.1K 0.04% 513
2019
Q3
$218K Sell
2,388
-6,685
-74% -$609K 0.04% 430
2019
Q2
$885K Buy
9,073
+4,500
+98% +$438K 0.18% 156
2019
Q1
$461K Buy
+4,573
New +$408K 0.09% 306
2017
Q2
Sell
-4,752
Closed -$427K 455
2017
Q1
$427K Sell
4,752
-9,448
-67% -$814K 0.2% 193
2016
Q4
$1.23M Buy
+14,200
New +$1.27M 0.3% 94
2016
Q2
Sell
-3,717
Closed -$392K 418
2016
Q1
$392K Buy
+3,717
New +$356K 0.37% 90

Other funds holding CRI

Bayesian Capital Management's CRI Position: Q4 2024 in Review

Bayesian Capital Management sold out of Carter's (CRI) in Q4 2024, closing a stake of 20,300 shares — an estimated $1.32M sold.

Bayesian Capital Management first reported a position in CRI in Q1 2016 and held it in 12 quarters. The position peaked at $1.32M in Q3 2024. 317 funds tracked by Wall St. Rank hold CRI as of Q4 2024.

  • Bayesian Capital Management reported no remaining Carter's position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 20,300 Carter's shares in Q4 2024, an estimated $1.32M.
  • Bayesian Capital Management first reported a position in Carter's in Q1 2016 and held it in 12 quarters.
  • Bayesian Capital Management's Carter's position peaked at $1.32M in Q3 2024.
  • 317 funds tracked by Wall St. Rank held Carter's as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.